Sidley, Austin et al
Campaign Finance
$934,698 Given
Information
Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:
- contributions under $200 are not reported, and so are not included in totals.
- only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
- contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
- corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
- organization totals include known subsidiaries of the organization.
For more information, please see our campaign finance methodology page. Lobbyist bundling data is described on our lobbyist bundling methodology page.
covers through Q3 2012
-
Top Recipients
- Employee Color Block
- Individuals
- PAC Color Block
- PAC
-
Republicans vs. Democrats
in dollars. "Other" includes 3rd parties and organizations without official party affiliation. -
State vs. Federal
in dollars -
Top PAC Recipients
- Employee Color Block
- Individuals
- PAC Color Block
- PAC
Lobbying
$28,800,831 Income
Information
Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
covers roughly through Q3, 2012
Lobbying Carried Out by Sidley, Austin et al
-
Names of Lobbyists
-
Client Amount MasterCard International $5,580,000 Talecris Biotherapeutics $2,220,000 Pharmaceutical Rsrch & Mfrs of America $1,700,000 Sepracor Inc $1,690,000 Bayer Healthcare $950,000 Monsanto Co $930,000 Specialty & Biotech Distributors Assn $920,000 Genentech Inc $880,000 American Electric Power $880,000 Rio Tinto Borax $710,000 -
Most Frequently Disclosed Lobbying Issues
- Medicare & Medicaid,
- Trade,
- Health Issues,
- Environment & Superfund,
- Copyright, Patent & Trademark,
- Banking,
- Finance,
- Taxes,
- Food Industry,
- Bankruptcy
-
Most Frequently Disclosed Bills
Bill No. Title H.R.958 Data Accountability and Trust Act S.495 Personal Data Privacy and Security Act of 2007 S.1178 Identity Theft Prevention Act H.R.583 Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007 S.1042 Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2007 H.R.873 Credit Card Payment Fee Act of 2007 H.R.946 Consumer Overdraft Protection Fair Practices Act H.R.2146 Universal Default Prohibition Act of 2007 H.R.2911 Electronic Funds Transfer Equal Consumer Protection Act S.980 Ryan Haight Online Pharmacy Consumer Protection Act of 2007 -
Recent Lobbying Contracts
Date Client Summary April 8, 2013 Covidien Ltd Educate federal agencies and congressional offices on the continuing need for specific nuclear reactors around the world to be available for the production of supplies of a radioactive material (molybdenum-99, or Mo-99) sufficient for Mallinckrodt (the pharmaceutical business of Covidien) to manufacture its Tc-99m generator medical-imaging radiopharmaceutical product View registration
